Redhill Biopharma
RDHL
C$2.04
Share price
-9.20%
Change (1 day)
-85.03%
Change (1 year)
Categories
EPS for Redhill Biopharma (RDHL)
EPS in 2023 (TTM): C-$907.70
According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is C-$963.82. In 2017 the company made an earnings per share (EPS) of C-$3,442 a decrease over its 2016 EPS that were of C-$3,029.
EPS history for Redhill Biopharma from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | C-$907.70 | |
| 2017 | C-$3,442 | 13.64% |
| 2016 | C-$3,029 | 9.12% |
| 2015 | C-$2,776 | 68.01% |
| 2014 | C-$1,652 | -25.93% |
| 2013 | C-$2,231 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | C$3.92 | -100.41% | 🇫🇷 France |
 Merck MRK | C$9.50 | -100.99% | 🇺🇸 USA |
 GlaxoSmithKline GSK | C$2.15 | -100.22% | 🇬🇧 UK |
 Taro Pharmaceutical TARO | C$1.68 | -100.17% | 🇮🇱 Israel |
 Teva Pharmaceutical Industries TEVA | C-$1.57 | -99.84% | 🇮🇱 Israel |